Study

Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS)

Study ID Alternative Stable ID Type
phs000670 Prospective

Study Description

This pharmacogenomic study focused on the response of patients with MDD to an 8-week course of treatment with citalopram or escitalopram.

Briefly, clinical assessments and research assessments were performed at each study visit as summarized in Table 1. Many patients continued on antidepressant medication after the 8 week study.

Table 1: Study timeline and patient contacts.

Week Consent/Med Hx Write Rx SI Qx SCID HRS-D17 QIDSC16 CGI-I
0 SC RC RC SC SC SC
4 RC RC SC SC RC
8 RC RC SC SC RC

HRS-D17=Hamilton Rating Scale for Depression, QIDS-C16=Quick Inventory of Depressive Symptomatology, CGI-I=Clinical Global Impression-Improvement, SCID=Structured Clinical Interview for DSM-IV, ... (Show More)

Archive Link Archive Accession
dbGaP phs000670

Who archives the data?

There are no publications available